Table 4.
SAL | 0.3 NIC | 1.0 NIC | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
MEC (mg/kg) | 0.25 | 0.50 | 0.75 | 1.0 | 0.25 | 0.50 | 0.75 | 1.0 | 0.25 | 0.50 | 0.75 | 1.0 |
Subject ID | ||||||||||||
JOL1 (16) | 13 | 17 | − 51 | 15 | 20 | 35 | 39 | − 17 | − 34 | − 25 | − 28 | − 04 |
JOL2 (40) | 37 | 42 | 42 | 11 | − 61 | − 71 | − 66 | − 81 | − 39 | − 52 | − 55 | − 63 |
JOL3 (16) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
JOL4 (40) | 62 | 42 | 40 | − 16 | 23 | 29 | − 100 | 09 | 50 | 72 | − 46 | 81 |
JOL5 (16) | − 26 | − 20 | 27 | 52 | − 11 | − 36 | − 07 | 17 | − 25 | − 23 | − 06 | − 58 |
JOL6 (40) | 53 | − 10 | 15 | − 112 | − 83 | − 46 | − 23 | − 33 | − 51 | − 18 | − 55 | 01 |
Mean | 28 | 14 | 14 | − 10 | − 22 | − 18 | − 32 | − 21 | − 20 | − 12 | − 37 | − 09 |
SEM | 14 | 12 | 20 | 25 | 19 | 19 | 24 | 18 | 16 | 30 | 11 | 26 |
JOF1 (16) | − 12 | 73 | 19 | − 28 | − 22 | − 45 | − 38 | − 45 | − 95 | − 80 | − 46 | − 22 |
JOF2 (16) | 05 | 16 | − 03 | 2 | − 38 | − 29 | − 17 | 58 | − 35 | − 29 | − 47 | 13 |
JOF3 (16) | 33 | − 29 | 18 | − 31 | − 44 | − 19 | 23 | − 67 | − 31 | − 59 | − 50 | − 72 |
JOF4 (16) | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
JOF5 (16) | 04 | − 60 | − 208 | − 21 | 11 | − 02 | − 44 | − 28 | − 21 | 09 | − 23 | 02 |
JOF6 (40) | − 26 | − 28 | − 22 | − 138 | − 47 | − 50 | − 41 | − 42 | − 02 | 48 | 23 | 55 |
Mean | 01 | − 04 | − 55 | − 43 | − 28 | − 30 | − 24 | − 24 | − 33 | − 25 | − 39 | − 06 |
SEM | 32 | 29 | 54 | 22 | 19 | 13 | 17 | 22 | 13 | 25 | 18 | 18 |
Percent change values at each dose of MEC pretreatment refers to change from the corresponding NIC-SAL dose combination. Values in parenthesis next to subject IDs refer to the delay series on which individual rats responded